Physician profile
Monisha Chadha
NPI 1427176957
$1,511.55
in general payments reported to CMS, 2019-2025
17 companies · $518 in 2025
The $518 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2020: $45.74 · 2021: $88.96 · 2022: $250 · 2024: $375 · 2025: $518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $893.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $221.28 | 2024-2025 | Freestyle Libre 3 |
| Dexcom, INC. | $195.80 | 2019-2022 | |
| Novo Nordisk INC | $188.44 | 2019-2025 | Ozempic |
| Beta Bionics, INC. | $135.41 | 2024 | Ilet Bionic Pancreas |
| Takeda Pharmaceuticals U.S.A., INC. | $125.00 | 2022 | |
| Corcept Therapeutics | $124.54 | 2025 | Korlym |
| Sanofi-Aventis U.S. LLC | $87.34 | 2024 | |
| Alexion Pharmaceuticals, INC. | $84.22 | 2025 | Strensiq |
| Valeritas, INC. | $70.96 | 2019 | |
| Medtronic, INC. | $59.29 | 2021 | |
| Sunovion Pharmaceuticals INC. | $55.78 | 2019 | |
| Amgen INC. | $49.99 | 2025 | Evenity |
| Insulet Corporation | $35.00 | 2019 | |
| Kyowa Kirin, INC. | $33.79 | 2024 | Crysvita |
| Exact Sciences Corporation | $17.25 | 2025 | The Cologuard Plus Collection Kit |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Soleno Therapeutics, INC. | $14.88 | 2025 | Vykat Xr |
| Companion Medical, INC. | $12.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monisha Chadha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.